NeuronSifter improves planning of CNS interventions by modeling microenvironment dynamics
NeuronSifter: Intervention Planning in CNS Microenvironments
Machine Learning
Summary
Treating brain treatments as simple numbers hides important details about where and when drugs work in brain tissue. The authors created NeuronSifter, a method that models how treatments affect specific brain microenvironments over time and uses this to better plan interventions. By predicting how a treatment impacts brain cells and deciding the best measurements to improve decisions, NeuronSifter more accurately ranks treatment options. Tests in a simulated Alzheimer's disease setting show it improves prediction accuracy and lowers treatment risk compared to earlier methods.
What this means in practice
- •For clinical trial designers: Plan and prioritize CNS treatment regimens by modeling drug action in specific brain microenvironments and selecting informative measurements to reduce uncertainty.
- •For pharmaceutical development teams: Use microenvironment-aware predictions to optimize dosing schedules and administration routes for CNS-targeted drugs in preclinical and clinical studies.
Authors
Haowei Xu, Wanyi Fu, Hongbin Han, Zhaoheng Xie
Abstract
Prioritizing central nervous system (CNS) interventions requires predicting how a dose, route, and schedule act on a partially observed microenvironment, then choosing the measurement that would change the decision. Action-conditioned predictors reduce a regimen to an identity token or a scalar exposure, discarding where and when the target is engaged; handing a point estimate to a separate planner then discards the joint uncertainty that makes a measurement worth running. We therefore treat decision quality as a property of the intervention interface, not of controller placement. NeuronSifter compiles regimens into state-conditional target-occupancy fields with support masks, propagates them through microenvironment dynamics with an occupancy-conditioned diffusion operator, and selects measurements by their expected reduction in intervention loss, assimilating typed outcomes into the same posterior. In a declared synthetic Alzheimer's disease (AD) evaluation over 64 paired scenario blocks, occupancy conditioning lowers trajectory continuous ranked probability score from 0.165 to 0.110 and raises intervention ordering accuracy from 0.760 to 0.880, and every paired benchmark contrast remains separated after Holm correction. Decision-directed acquisition attains terminal risk 0.160 against 0.166 for a matched numerical Bayesian experimental design planner, and reaches the target risk at 0.796 $[0.732,0.873]$ of an earlier design control's cost, while the corresponding ratio against the matched planner, 0.963 $[0.907,1.025]$, is not separated from equality; point-state and dependence-ablated interfaces instead raise risk to 0.220 and 0.199, and a full-posterior external controller ties exactly. Published AD trials supply a separate retrospective endpoint bridge.